Orphan Drugs & Rare Diseases
Turkiye has unique demographics with higher incidences of rare hereditary diseases. MonitorCRO has excellent experience with orphan drug applications and follow-up inspections with the Ministry of Health.
Key Highlights
Access to unique patient populations with rare hereditary diseases
Orphan drug designation application support
Ministry of Health inspection follow-up expertise
Patient identification and recruitment strategies
Regulatory pathway optimization for rare diseases
Long-term follow-up study management